objective to review the current management of women with breast painoptions the effect of various treatment modes and health practices including medications was considered for the management of both cyclical and noncyclical breast painoutcomes effective and timely management of the woman with breast pain and improved quality of lifeevidence a literature search was performed to identify reports published in english between 1975 and july 2003 using medline and cochrane database of systematic reviewsvalues levels of evidence as outlined have been determined using the criteria outlined by the canadian task force on the periodic health examinationparticipants were the principal authors a clinical dietitian a surgeon oncologist and a nursebenefits harms and costs utilizing the information will increase knowledge enabling a consistent approach which will reduce the number of ineffective interventions and ensure appropriate use medicationsvalidation comparison has been made with management protocols in the literature but no clinical guidelines have been locatedno formal clinical testing has taken placesponsor the society of obstetricians and gynaecologists of canada sogcwork on these guidelines was initiated by team members to fill a need for practice guidelines at winnipeg regional health authority breast health centre winnipeg mbrecommendations 1education and reassurance is an integral part of the management of mastalgia and should be the firstline treatmentii1 a 2the use of a wellfitting bra that provides good support should be considered for the relief of cyclical and noncyclical mastalgiaii3 b 3a change in dose formulation or scheduling should be considered for women on hrthrt may be discontinued if appropriateiii c 4women with breast pain should not be advised to reduce caffeine intake1 e 5vitamin e should not be considered for the treatment of mastalgia1 e 6there is presently insufficient evidence to recommend the use of evening primrose oil epo in the treatment of breast painii2 c 7flaxseed should be considered as a firstline treatment for cyclical mastalgiai a 8topical nonsteroidal antiinflammatory gel such as diclofenac 2 in pluronic lethicin organogel should be considered for pain control for localized treatment of mastalgiai a 9tamoxifen 10 mg daily or danazol 200 mg daily should be considered when firstline treatments are ineffectivei a 10mastectomy or partial mastectomy should not be considered an effective treatment for mastalgiaiii e